Malignancy-associated Immunodeficiency

Malignancy-Associated Immunodeficiency is a secondary immunodeficiency characterized by impaired immune function resulting directly from the pathophysiological effects of malignant cells, their secreted products, or cancer-induced alterations in immune regulation.

243

Publications

13.8K

Citations

1.3K

Authors

438

Institutions

Publications per year

2017–2026

21

Authors

1.3K

  1. UT
    Umberto Tirelli

    Centro di Riferimento Oncologico, Italy

    6 publications · 359 citations

    6

    h-index

  2. RY
    Robert Yarchoan

    National Cancer Institute, United States

    5 publications · 690 citations

    5

    h-index

  3. EV
    Emanuela Vaccher

    Centro di Riferimento Oncologico, Italy

    5 publications · 345 citations

    5

    h-index

  4. RC
    Robert C. Gallo

    National Cancer Institute, United States

    5 publications · 930 citations

    5

    h-index

  5. RA
    Robert A. Good

    University of Minnesota, United States

    4 publications · 226 citations

    4

    h-index

1–5 of 1.3K

Venues

  1. PubMed

    Repository · 39 publications · 1.9K citations

    18

    h-index

  2. Cancer

    15 publications · 883 citations

    14

    h-index

  3. Blood

    13 publications · 788 citations

    12

    h-index

  4. The American Journal of Medicine

    8 publications · 393 citations

    8

    h-index

  5. Clinical Infectious Diseases

    CID · 5 publications · 451 citations

    6

    h-index

1–5